article thumbnail

Pharma manufacturing can digitalise its way round the next crisis

pharmaphorum

The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis. The net effect has been to stimulate change in every aspect of the pharma industry – an industry not exactly known for its embrace of manufacturing innovation.

article thumbnail

The hypocrisy of big pharma

World of DTC Marketing

When we asked you to rapidly expand manufacturing so we can produce 3, 4 billion doses per year, you did it,” Bourla said. And Pfizer said “no” The government is the largest purchaser of prescription drugs, and they should be allowed to negotiate prices with pharma companies whose profit margins are the highest of any industry.

Pharma 214
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AbbVie continues to be what’s wrong with big pharma

World of DTC Marketing

I continue to believe that there are very good people who care about patients working within pharma but it’s hard to understand how anyone who works for AbbVie can feel good about their employer. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S.

Pharma 202
article thumbnail

Pharma is “big business” that uses excuses to keep prices high

World of DTC Marketing

Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices. Big Pharma’s chokehold around the U.S. Via Axios “The 10 highest-selling drugs in the U.S.

Pharma 241
article thumbnail

And so pharma profiteers again

World of DTC Marketing

This comes at a time when industry fart sniffing publications like Fierce Pharma report “pharma continues to shine under the pandemic spotlight. Pharma earned a solid No. Best of all are patients in the US, where prices are highest, and with chronic conditions requiring repeat prescriptions.

Pharma 191
article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

article thumbnail

Should we be worried about pharma’s supply chain?

World of DTC Marketing

QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. Hedley Rees has written a book on pharma supply chains that is eye-opening and downright scary. Can patients really be confident in pharma supply chains? Why would a pharma company take risks like these? Patients should be scared.